STAAR Surgical Names New CFO, Awards 41,867 Restricted Stock Units

Staar Surgical has reported a significant insider transaction involving their newly appointed Chief Financial Officer, Deborah J. Andrews.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Staar Surgical has reported a significant insider transaction involving their newly appointed Chief Financial Officer, Deborah J. Andrews. On June 25, 2025, Andrews received a grant of 41,867 Restricted Stock Units (RSUs) as part of her appointment compensation package.

Key details of the RSU grant:

Each RSU represents the right to receive one share of common stock upon vesting
The RSUs will vest in three equal annual installments on June 25 of 2026, 2027, and 2028
The conversion price is $0, typical for RSU grants
The shares are held directly by Andrews

This Form 4 filing indicates a standard executive compensation arrangement, designed to align the new CFO's interests with long-term shareholder value through a three-year vesting schedule. The transaction was reported within the required two-business-day window for insider transaction disclosure.

Positive

New CFO Deborah Andrews received significant equity alignment with 41,867 RSUs vesting over 3 years, demonstrating long-term commitment and alignment with shareholder interests

Negative

None.

Insider Trade Summary

Grant/Award: 41,867 shares

Grant/Award 1 txn

Insider ANDREWS DEBORAH J

Role CFO

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	41,867	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 41,867 contracts (Direct)

Footnotes (2)

F1. Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting.
F2. Award of RSUs granted to the Reporting Person on June 25, 2025. These RSUs will vest as to 1/3 of the shares subject to the award on each of June 25, 2026, 2027 and 2028.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Restricted Stock Units (RSUs) did STAA's new CFO Deborah Andrews receive?

Deborah Andrews received 41,867 Restricted Stock Units (RSUs) from STAAR Surgical Co on June 25, 2025, in connection with her appointment as Chief Financial Officer.

What is the vesting schedule for STAA CFO Deborah Andrews' RSUs granted in June 2025?

The RSUs will vest in three equal installments, with 1/3 of the shares vesting on each of June 25, 2026, 2027, and 2028.

When was Deborah Andrews appointed as CFO of STAA?

According to the Form 4 filing remarks, Deborah Andrews was appointed as Chief Financial Officer of STAAR Surgical Co on June 25, 2025.

What is the conversion price of STAA's RSUs granted to CFO Deborah Andrews?

The conversion price for the RSUs is $0, as each restricted stock unit represents the right to receive one share of STAAR Surgical's common stock upon vesting.

Where is STAA's new CFO Deborah Andrews based?

According to the Form 4 filing, Deborah Andrews' business address is 25510 Commercentre Drive, Lake Forest, CA 92630.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/26/2025 - 06:31 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ANDREWS DEBORAH J

(Last)

(First)

(Middle)

25510 COMMERCENTRE DRIVE

(Street)

LAKE FOREST

92630

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
STAAR SURGICAL CO [ STAA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	$0⁽¹⁾	06/25/2025		A		41,867		⁽²⁾	⁽²⁾	Common Stock	41,867	$0	41,867	D

Explanation of Responses:

1. Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting.

2. Award of RSUs granted to the Reporting Person on June 25, 2025. These RSUs will vest as to 1/3 of the shares subject to the award on each of June 25, 2026, 2027 and 2028.

Remarks:

This Form 4 reflects the RSUs granted to Ms. Andrews in connection with her appointment as Chief Financial Officer on June 25, 2025.

	/s/ Nathaniel Sisitsky as attorney-in-fact for Deborah Andrews	06/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR